| Followers | 832 |
| Posts | 119956 |
| Boards Moderated | 17 |
| Alias Born | 09/05/2002 |
Tuesday, October 17, 2006 5:13:05 PM
> ITMN VRTX – Have a lot of thoughts on what this deal means for HCV drug development especially for Vertex (surprised others aren’t speculating)…<
Some people are speculating about this. ‘stymiefool’ posted on Yahoo that people “in the know” are telling him VX-950 won’t make it. (My own opinion is that Mr. Stymie overdid his celebration.)
> anyone know if there will be anywhere that we can get information on what the FDA decides for HCV clinical development in the meetings the next couple days?<
If you wanted to dedicate 12 hours and a few hundred bucks, you could listen to the panel hearings live via fdaadvisorycommittee.com. But I wouldn’t bother (even if money were no object) because the outcome of the hearings will be well publicized. Regards, Dew
p.s. I think it’s time for you to update the ITMN ReadMeFirst
I suggest copying the old text into your word processor and making edits there. Post your new text as a message in reply to your old one. I will then update the pointer in the iBox.
Some people are speculating about this. ‘stymiefool’ posted on Yahoo that people “in the know” are telling him VX-950 won’t make it. (My own opinion is that Mr. Stymie overdid his celebration.)
> anyone know if there will be anywhere that we can get information on what the FDA decides for HCV clinical development in the meetings the next couple days?<
If you wanted to dedicate 12 hours and a few hundred bucks, you could listen to the panel hearings live via fdaadvisorycommittee.com. But I wouldn’t bother (even if money were no object) because the outcome of the hearings will be well publicized. Regards, Dew
p.s. I think it’s time for you to update the ITMN ReadMeFirst
I suggest copying the old text into your word processor and making edits there. Post your new text as a message in reply to your old one. I will then update the pointer in the iBox. “The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
